BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2785765&ei=oIaaUqDjE4qw0AGZAw&usg=AFQjCNEFCJMHdv6z2JbnJP7RzEvuWlAXWg
Biogen Idec Inc Receives License For Novel Mouse Model From Myelin Repair Foundation
Monday, 1 Jul 2013 08:00am EDT
Biogen Idec Inc announced that The Myelin Repair Foundation has granted a non-exclusive sublicense to Biogen Idec for the use of MRF's technologies to generate a novel mouse model for all demyelinating diseases, including multiple sclerosis (MS). Biogen Idec, an independent biotechnology company with a strong focus on multiple sclerosis therapies, will use the MRF technology in its in-house drug discovery programs. The Myelin Repair Foundation and Biogen Idec will collaborate to improve the licensed technologies to enhance discovery of myelin repair therapeutics and speed clinical development.Â 
